Atara Biotherapeutics (ATRA) SEC Filings & 10K Form

$0.71
0.00 (0.00%)
(As of 04/24/2024 ET)

Recent Atara Biotherapeutics SEC Filings

DateFilerForm TypeView
04/12/2024
3:15 PM
Atara Biotherapeutics (Filer)
Atara Biotherapeutics (Filer)
Form PRE 14A
04/02/2024
5:11 PM
Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:13 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:40 AM
Atara Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:35 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
5:18 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:18 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:19 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:16 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:17 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
7:17 PM
Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:18 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:19 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:21 PM
Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:13 PM
Atara Biotherapeutics (Subject)
Nguyen Tran (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
3:45 PM
Atara Biotherapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
01/22/2024
12:58 PM
Atara Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:41 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Atara Biotherapeutics (Filer)
Form 424B5
01/09/2024
3:22 PM
Atara Biotherapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
Form SC 13G/A
01/08/2024
7:11 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
11/20/2023
4:31 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:31 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:29 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:29 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:30 PM
Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:30 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:31 PM
Atara Biotherapeutics (Filer)
Form 424B3
11/14/2023
5:27 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
5:29 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Will this $2 AI stock double overnight? (Ad)

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

Click here to learn more >>>
11/13/2023
11:15 PM
Atara Biotherapeutics (Filer)
Form EFFECT
11/08/2023
8:16 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
4:25 PM
Atara Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/01/2023
7:35 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
7:40 AM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
3:15 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
7:06 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:08 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
7:17 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
7:17 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
7:17 PM
Atara Biotherapeutics (Issuer)
Banard Charlene A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
7:17 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ATRA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners